Skip to content

Vertex Monitoring Catheter

by Vertex Medical Corp.

510(k) K823253

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK823253 Date30 Dec 1982ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXT
Device Class
Class II
Regulation
21 CFR Part 870.1650
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Vertex Monitoring Catheter is classified as an Injector and Syringe, Angiographic device, designed for intravascular monitoring and fluid delivery during cardiovascular procedures. It facilitates real-time pressure and flow measurements within coronary or peripheral arteries, aiding in diagnostic and interventional assessments.

This catheter is intended for single-use in controlled clinical settings, such as cardiac catheterization labs. Supplied sterile and packaged for immediate use, it adheres to FDA 510(k) clearance (K823253) under regulatory classification DXT, with no noted MRI compatibility restrictions. Sizes and configurations are specified in the associated submissions, though exact dimensions are not detailed in the provided data.

Other devices from Vertex Medical Corp.

See all devices from Vertex Medical Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of procedures is the Vertex Monitoring Catheter designed to support in a clinical setting?

    The Vertex Monitoring Catheter is specifically designed for use in cardiovascular procedures, particularly within cardiac catheterization labs. It facilitates real-time pressure and flow measurements in coronary or peripheral arteries, making it useful for both diagnostic assessments and interventional procedures where precise intravascular monitoring is required.

  • Is the Vertex Monitoring Catheter intended for single-use or repeated use in a clinical environment?

    The Vertex Monitoring Catheter is explicitly intended for single-use only. It is supplied sterile and packaged for immediate use in controlled clinical settings, ensuring compliance with best practices for patient safety and infection control.

  • How is the Vertex Monitoring Catheter supplied, and what does this mean for its readiness for use?

    The Vertex Monitoring Catheter is supplied sterile and pre-packaged for immediate use. This means it is ready to deploy directly from its packaging without requiring additional sterilization or preparation, streamlining workflow in the catheterization lab.

  • Are there any specific storage requirements or restrictions mentioned for the Vertex Monitoring Catheter?

    The provided data does not specify detailed storage requirements, but since it is a single-use, sterile device, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures. Always follow manufacturer guidelines for optimal shelf life and sterility preservation.

  • What regulatory pathway was followed for the Vertex Monitoring Catheter’s clearance, and what does this imply for its use?

    The Vertex Monitoring Catheter received FDA 510(k) clearance under the classification DXT (Injector and Syringe, Angiographic) with a decision of *Substantially Equivalent* (SESE). This means it was determined to be comparable to legally marketed devices in terms of safety and effectiveness, allowing it to be used in clinical settings as described in its labeling for intravascular monitoring and fluid delivery.